Qlucore AB (publ) Asset Resilience Ratio

Latest as of December 2011: 0.17%

Qlucore AB (publ) asset resilience ratio. Qlucore AB (publ) (NOVKAN) has an Asset Resilience Ratio of 0.17% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Qlucore AB (publ) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr67.00K
≈ $7.21K USD Cash + Short-term Investments

Total Assets

Skr39.74 Million
≈ $4.28 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Qlucore AB (publ) (2010–2011)

Asset resilience ratio of Qlucore AB (publ) from 2010 to 2011. This chart shows how Qlucore AB (publ)'s Asset Resilience Ratio has changed over time. See Qlucore AB (publ) free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Qlucore AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Qlucore AB (publ) (NOVKAN) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr67.00K 0.17%
Total Liquid Assets Skr67.00K 0.17%

Asset Resilience Insights

  • Limited Liquidity: Qlucore AB (publ) maintains only 0.17% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Qlucore AB (publ) Industry Peers by Asset Resilience Ratio

Compare Qlucore AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
BB Biotech AG
SW:BION
Biotechnology 92.97%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
Innovita Biological Technology Co. Ltd. A
SHG:688253
Biotechnology 65.12%
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
Biotechnology 4.57%
Eupraxia Pharmaceuticals Inc
TO:EPRX
Biotechnology 25.13%
Cabio Biotech Wuhan Co Ltd
SHG:688089
Biotechnology 3.60%

Qlucore AB (publ) Asset Resilience Ratio by Year (2010–2011)

Qlucore AB (publ) asset resilience ratio by year from 2010 to 2011. The table below shows the annual Asset Resilience Ratio data for Qlucore AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2011-12-31 0.17% Skr67.00K
≈ $7.21K
Skr39.74 Million
≈ $4.28 Million
-3.40pp
2010-12-31 3.57% Skr500.00K
≈ $53.81K
Skr14.01 Million
≈ $1.51 Million
--
pp = percentage points

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology
Market Cap
$326.04K
Skr3.03 Million SEK
Market Cap Rank
#31228 Global
#6340 in USA
Share Price
Skr0.03
Change (1 day)
-43.95%
52-Week Range
Skr0.03 - Skr0.23
All Time High
Skr0.23
About

Novakand Pharma AB (publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase II study in healthy subjects to document desired dose levels against cancer; and Phase IIa study… Read more